Skip to main content
Erschienen in: Neurological Sciences 5/2012

01.10.2012 | Original Article

Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment

verfasst von: M. Badruzzaman Khan, Md. Nasrul Hoda, Tauheed Ishrat, Saif Ahmad, Mohd. Moshahid Khan, Ajmal Ahmad, Seema Yusuf, Fakhrul Islam

Erschienen in: Neurological Sciences | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Oxidative stress leads to complex biochemical alterations, and has been implicated in the progressive loss of learning and memory. Supplementing and boosting the endogenous antioxidant defense system could impede the progression of various types of neurodegeneration. In the present study, we have investigated the neuroprotective efficacy of a low-dose combination of certain promising and powerful natural antioxidants in an experimental model of cognitive impairment. Combined pretreatment with the extract of Nardosatchys jatamansi (N), crocetin (C) and selenium (Se) as sodium selenite (N, 200 mg/kg + C, 25 μg/kg + Se, 0.05 mg/kg body weight) for 15 days led to improved behavioral outcomes in streptozotocin (STZ)-induced cognitive impairment in rats. While intracerebroventricular (ICV) infusion of STZ resulted in the significant elevation of markers of oxidative stress and depletion of endogenous antioxidant defense system in the vehicle-pretreated group, these markers of oxidative stress and antioxidant enzymatic as well as non-enzymatic defense lines were attenuated in the group pretreated with the combination of antioxidants (NCSe). NCSe pretreatment markedly improved the performance of animals in passive avoidance test and Morris water maze (MWM) tasks, significantly reduced the level of TBARS, and elevated the content of glutathione and activities of antioxidant enzymes (glutathione peroxidase, glutathione-S-transferase and catalase). Our study reflects the synergistic potential of the above combination and concludes that a multimodal approach could be beneficial rather than a singular intervention.
Literatur
1.
Zurück zum Zitat Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609–1623PubMedCrossRef Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609–1623PubMedCrossRef
2.
Zurück zum Zitat Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689–695PubMedCrossRef Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689–695PubMedCrossRef
3.
4.
Zurück zum Zitat Mate′s JM, Pe′rez-Go′mez C, Castro C (1999) Antioxidant enzymes and human diseases. Clin Biochem 32:595–603CrossRef Mate′s JM, Pe′rez-Go′mez C, Castro C (1999) Antioxidant enzymes and human diseases. Clin Biochem 32:595–603CrossRef
5.
Zurück zum Zitat Alexi T, Borlongan CV, Faull RLM, Williams CE, Clark RG, Gluckman PD, Hughes PE (2000) Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases. Prog Neurobiol 60:409–470PubMedCrossRef Alexi T, Borlongan CV, Faull RLM, Williams CE, Clark RG, Gluckman PD, Hughes PE (2000) Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases. Prog Neurobiol 60:409–470PubMedCrossRef
6.
Zurück zum Zitat Halliwell B, Gutteridge JMC (1999) Free radicals in biology and medicine, 3rd edn. Oxford University Press, New York Halliwell B, Gutteridge JMC (1999) Free radicals in biology and medicine, 3rd edn. Oxford University Press, New York
7.
Zurück zum Zitat Urano S, Asai Y, Makabe S, Matsuo M, Izumiyama N, Ohtsubo K, Endo T (1997) Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E. Eur J Biochem 245:64–70PubMedCrossRef Urano S, Asai Y, Makabe S, Matsuo M, Izumiyama N, Ohtsubo K, Endo T (1997) Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E. Eur J Biochem 245:64–70PubMedCrossRef
8.
Zurück zum Zitat Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito KI, Kogure K (1997) Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 762:240–242PubMedCrossRef Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito KI, Kogure K (1997) Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 762:240–242PubMedCrossRef
9.
Zurück zum Zitat Bastianetto S, Ramassamy C, Poirier J, Quiron R (1999) Dehydroepiandrosterone DHEA protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66:35–41PubMedCrossRef Bastianetto S, Ramassamy C, Poirier J, Quiron R (1999) Dehydroepiandrosterone DHEA protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66:35–41PubMedCrossRef
10.
Zurück zum Zitat Blokland A, Jolles J (1993) Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol Biochem Behav 44:491–494PubMedCrossRef Blokland A, Jolles J (1993) Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol Biochem Behav 44:491–494PubMedCrossRef
11.
Zurück zum Zitat Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199–1208PubMedCrossRef Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199–1208PubMedCrossRef
12.
Zurück zum Zitat Chatterjee A, Prakashi SC (1997) The treatise on Indian medicinal plants, vol 5. National Institute of Science Communication, New Delhi, pp 99–100 Chatterjee A, Prakashi SC (1997) The treatise on Indian medicinal plants, vol 5. National Institute of Science Communication, New Delhi, pp 99–100
13.
Zurück zum Zitat Arora RB (1965) Nardostachys jatamansi—a chemical, pharmacological and clinical appraisal. Monograph Special Series, vol 51. ICMR, New Delhi Arora RB (1965) Nardostachys jatamansi—a chemical, pharmacological and clinical appraisal. Monograph Special Series, vol 51. ICMR, New Delhi
14.
Zurück zum Zitat Rastogi BR, Mehrotra K (1990) Compendium of Indian medicinal plants, 4th edn. Public Information Directorate, CSIR, New Delhi, pp 286–287 Rastogi BR, Mehrotra K (1990) Compendium of Indian medicinal plants, 4th edn. Public Information Directorate, CSIR, New Delhi, pp 286–287
15.
Zurück zum Zitat Tripathi YB, Tripathi E, Upadhyaya A (1996) Antilipid peroxidative property of Nardostachys jatamansi. Indian J Exp Biol 34:1150–1161PubMed Tripathi YB, Tripathi E, Upadhyaya A (1996) Antilipid peroxidative property of Nardostachys jatamansi. Indian J Exp Biol 34:1150–1161PubMed
16.
Zurück zum Zitat Joshi H, Parle M (2006) Nardostachys jatamansi improves learning and memory in mice. J Med Food 9:113–118PubMedCrossRef Joshi H, Parle M (2006) Nardostachys jatamansi improves learning and memory in mice. J Med Food 9:113–118PubMedCrossRef
17.
Zurück zum Zitat Ahmad M, Yousuf S, Khan MB, Hoda MN, Ahmad AS, Ansari MA, Ishrat T, Agrawal AK, Islam F (2006) Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav 83:150–160PubMedCrossRef Ahmad M, Yousuf S, Khan MB, Hoda MN, Ahmad AS, Ansari MA, Ishrat T, Agrawal AK, Islam F (2006) Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav 83:150–160PubMedCrossRef
18.
Zurück zum Zitat Salim S, Ahmad M, Zafar KS, Ahmad AS, Islam F (2003) Protective effect of Nardostachys jatamansi in rat cerebral ischemia. Pharmacol Biochem Behav 74:481–486PubMedCrossRef Salim S, Ahmad M, Zafar KS, Ahmad AS, Islam F (2003) Protective effect of Nardostachys jatamansi in rat cerebral ischemia. Pharmacol Biochem Behav 74:481–486PubMedCrossRef
19.
Zurück zum Zitat Singh A, Kumar A, Duggal S (2009) Nardostachys jatamansi DC. Potential herb with CNS effects. J Pharm Res Health Care 1:276–290 Singh A, Kumar A, Duggal S (2009) Nardostachys jatamansi DC. Potential herb with CNS effects. J Pharm Res Health Care 1:276–290
20.
Zurück zum Zitat Rios JL, Recio MC, Ginger RM, Manz S (1996) An update review of saffron and its active constituents. Phytother Res 10:189–193CrossRef Rios JL, Recio MC, Ginger RM, Manz S (1996) An update review of saffron and its active constituents. Phytother Res 10:189–193CrossRef
21.
Zurück zum Zitat Hosseinzadeh H, Khosravan V (2002) Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Irn Med 5:44–47 Hosseinzadeh H, Khosravan V (2002) Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Irn Med 5:44–47
22.
Zurück zum Zitat Hosseinzadeh H, Younesi HM (2002) Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2:1–8 Hosseinzadeh H, Younesi HM (2002) Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2:1–8
23.
Zurück zum Zitat Hosseinzadeh H, Karimi G, Niapoor M (2004) Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. Acta Hort ISHS 650:435–445 Hosseinzadeh H, Karimi G, Niapoor M (2004) Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. Acta Hort ISHS 650:435–445
24.
Zurück zum Zitat Abdullaev FJ (1993) Biological effects of saffron. Biofactors 4:83–86PubMed Abdullaev FJ (1993) Biological effects of saffron. Biofactors 4:83–86PubMed
25.
Zurück zum Zitat Escribano J, Alonso GL, Coca-Prados M, Fernandez JA (1996) Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett 100:23–30PubMedCrossRef Escribano J, Alonso GL, Coca-Prados M, Fernandez JA (1996) Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett 100:23–30PubMedCrossRef
26.
Zurück zum Zitat Zhang YX, Sugiura M, Saito H, Shoyama Y (1994) Acute effects of Crocus sativus L. on passive avoidance performance in mice. Biol Pharmacol Bull 17:217–221CrossRef Zhang YX, Sugiura M, Saito H, Shoyama Y (1994) Acute effects of Crocus sativus L. on passive avoidance performance in mice. Biol Pharmacol Bull 17:217–221CrossRef
27.
Zurück zum Zitat Abe K, Sugiura M, Ymaguchi S, Shoyama Y, Saito H (1999) Saffron extract prevents acetaldehyde-induced inhibition of long-term potentiation in the rat dentate gyrus in vivo. Brain Res 851:287–289PubMedCrossRef Abe K, Sugiura M, Ymaguchi S, Shoyama Y, Saito H (1999) Saffron extract prevents acetaldehyde-induced inhibition of long-term potentiation in the rat dentate gyrus in vivo. Brain Res 851:287–289PubMedCrossRef
28.
Zurück zum Zitat Papandreou MA, Kanakis CD, Polissiou MG, Efthimiopoulos S, Cordopatis P, Margarity M, Lamari FN (2006) Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem 54:8762–8768PubMedCrossRef Papandreou MA, Kanakis CD, Polissiou MG, Efthimiopoulos S, Cordopatis P, Margarity M, Lamari FN (2006) Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem 54:8762–8768PubMedCrossRef
29.
Zurück zum Zitat Ahmad AS, Ansari MA, Ahmad M, Saleem S, Yousuf S, Hoda MN, Islam F (2005) Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 81:805–813PubMedCrossRef Ahmad AS, Ansari MA, Ahmad M, Saleem S, Yousuf S, Hoda MN, Islam F (2005) Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 81:805–813PubMedCrossRef
30.
Zurück zum Zitat Schwarz K, Folz CM (1957) Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. Nutrition 15:255–264 Schwarz K, Folz CM (1957) Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. Nutrition 15:255–264
31.
Zurück zum Zitat Brauer AU, Savaskan NE (2004) Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element. Rev Neurosci 15:1–19CrossRef Brauer AU, Savaskan NE (2004) Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element. Rev Neurosci 15:1–19CrossRef
32.
Zurück zum Zitat Harman D (1993) Free radicals and age-related diseases. In: Pal YB (ed) Free radicals in aging. CRC Press, Boca Raton, pp 205–222 Harman D (1993) Free radicals and age-related diseases. In: Pal YB (ed) Free radicals in aging. CRC Press, Boca Raton, pp 205–222
33.
Zurück zum Zitat Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 97:2521–2526PubMedCrossRef Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 97:2521–2526PubMedCrossRef
34.
Zurück zum Zitat Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type. Brain Res 1281:117–127PubMedCrossRef Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type. Brain Res 1281:117–127PubMedCrossRef
35.
Zurück zum Zitat Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F (2003) Dose-dependent protective effect of selenium in rat model of Parkinson’s disease: neurobehavioral and neurochemical evidences. J Neurochem 84:438–446PubMedCrossRef Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F (2003) Dose-dependent protective effect of selenium in rat model of Parkinson’s disease: neurobehavioral and neurochemical evidences. J Neurochem 84:438–446PubMedCrossRef
36.
Zurück zum Zitat Yousuf S, Atif F, Hoda N, Ahmad M, Saleem S, Ishrat T, Khan MB, Ahmad AS, Islam F (2007) Oral supplementation of Majun Baladar ameliorates antioxidant enzyme activities in cerebral ischaemic damage. Basic Clin Pharmacol Toxicol 101:246–453PubMedCrossRef Yousuf S, Atif F, Hoda N, Ahmad M, Saleem S, Ishrat T, Khan MB, Ahmad AS, Islam F (2007) Oral supplementation of Majun Baladar ameliorates antioxidant enzyme activities in cerebral ischaemic damage. Basic Clin Pharmacol Toxicol 101:246–453PubMedCrossRef
37.
Zurück zum Zitat Halliwell B, Gutteridge JMC (1984) Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1:1396–1397PubMedCrossRef Halliwell B, Gutteridge JMC (1984) Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1:1396–1397PubMedCrossRef
38.
Zurück zum Zitat Westermarck T, Santavouri P (1984) Principles of antioxidant therapy in neuronal ceroid lipofuscinosis. Med Biol 62:148–151PubMed Westermarck T, Santavouri P (1984) Principles of antioxidant therapy in neuronal ceroid lipofuscinosis. Med Biol 62:148–151PubMed
39.
Zurück zum Zitat Khan MB, Hoda MN, Yousuf S, Ishrat T, Ahmad M, Ahmad AS, Alavi SH, Haque N, Islam F (2006) Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala. J Ethnopharmacol 108:68–73PubMedCrossRef Khan MB, Hoda MN, Yousuf S, Ishrat T, Ahmad M, Ahmad AS, Alavi SH, Haque N, Islam F (2006) Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala. J Ethnopharmacol 108:68–73PubMedCrossRef
40.
Zurück zum Zitat Prabhu VM, Karandh SK, Rao A, Vidya PM, Sudhakar K (1994) Effect of Nardostachys jatamansi on biogenic amines and inhibitory amino acids on rat brain. Planta Med 60:114–217PubMedCrossRef Prabhu VM, Karandh SK, Rao A, Vidya PM, Sudhakar K (1994) Effect of Nardostachys jatamansi on biogenic amines and inhibitory amino acids on rat brain. Planta Med 60:114–217PubMedCrossRef
41.
Zurück zum Zitat Ishrat T, Khan MB, Hoda MN, Yousuf S, Ahmad M, Ansari MA, Ahmad AS, Islam F (2006) Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 171:9–16PubMedCrossRef Ishrat T, Khan MB, Hoda MN, Yousuf S, Ahmad M, Ansari MA, Ahmad AS, Islam F (2006) Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 171:9–16PubMedCrossRef
42.
Zurück zum Zitat Olariu A, Tran MH, Yamada K, Mizuno M, Hefco V, Nabeshima T (2001) Memory deficits and increased emotionality induced by β-amyloid 25–35 are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. J Neural Transm 108:1065–1079PubMedCrossRef Olariu A, Tran MH, Yamada K, Mizuno M, Hefco V, Nabeshima T (2001) Memory deficits and increased emotionality induced by β-amyloid 25–35 are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. J Neural Transm 108:1065–1079PubMedCrossRef
43.
Zurück zum Zitat Sharma M, Gupta YK (2003) Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur Neuropsychopharm 13:241–247CrossRef Sharma M, Gupta YK (2003) Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur Neuropsychopharm 13:241–247CrossRef
44.
Zurück zum Zitat Morris R (1984) Development of the water maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47–60PubMedCrossRef Morris R (1984) Development of the water maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47–60PubMedCrossRef
45.
Zurück zum Zitat Gallagher M, Burwell R, Burchinal M (1993) Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 107:618–626PubMedCrossRef Gallagher M, Burwell R, Burchinal M (1993) Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 107:618–626PubMedCrossRef
46.
Zurück zum Zitat Utely HC, Bernheim F, Hochslein P (1967) Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 118:29–32CrossRef Utely HC, Bernheim F, Hochslein P (1967) Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 118:29–32CrossRef
47.
Zurück zum Zitat Islam F, Zia S, Sayeed I, Zafar KS, Ahmad AS (2002) Selenium induced alteration on lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat. Biol Trace Elem Res 90:1–12CrossRef Islam F, Zia S, Sayeed I, Zafar KS, Ahmad AS (2002) Selenium induced alteration on lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat. Biol Trace Elem Res 90:1–12CrossRef
48.
Zurück zum Zitat Jollow DJ, Mitchell JR, Zampagloine N, Gillete JR (1974) Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3, 4- bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151–169PubMedCrossRef Jollow DJ, Mitchell JR, Zampagloine N, Gillete JR (1974) Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3, 4- bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151–169PubMedCrossRef
49.
Zurück zum Zitat Mohandas J, Marshall JJ, Duggi GG, Horvath JS, Tiller D (1984) Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: possible implication in analgesic neuropathy. Cancer Res 44:5086–5091PubMed Mohandas J, Marshall JJ, Duggi GG, Horvath JS, Tiller D (1984) Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: possible implication in analgesic neuropathy. Cancer Res 44:5086–5091PubMed
50.
Zurück zum Zitat Habig WH, Pabst MJ, Jokoby B (1974) Glutathion-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139PubMed Habig WH, Pabst MJ, Jokoby B (1974) Glutathion-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139PubMed
51.
Zurück zum Zitat Athar M, Mukhtar H, Bickers DR, Khan IU, Kalyanaraman B (1989) Evidence for the metabolism of tumor promoter organic hydroperoxides into free radicals by human carcinoma skin keratinocytes: an ESR-spin trapping study. Carcinogenesis 10:1499–1503PubMedCrossRef Athar M, Mukhtar H, Bickers DR, Khan IU, Kalyanaraman B (1989) Evidence for the metabolism of tumor promoter organic hydroperoxides into free radicals by human carcinoma skin keratinocytes: an ESR-spin trapping study. Carcinogenesis 10:1499–1503PubMedCrossRef
52.
Zurück zum Zitat Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA (2000) Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006–1015PubMedCrossRef Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA (2000) Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006–1015PubMedCrossRef
53.
Zurück zum Zitat Claiborne A (1985) Catalase activity. In: Greenwald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 283–284 Claiborne A (1985) Catalase activity. In: Greenwald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 283–284
54.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275PubMed
56.
Zurück zum Zitat Zs-Nagy I (1990) Dietary antioxidants and brain aging: hopes and facts. In: Ingram DK, Baker GT, Shock NW (eds) The potential for nutritional modulation of aging processes. Food and Nutrition Press, Trumbell, pp 379–399 Zs-Nagy I (1990) Dietary antioxidants and brain aging: hopes and facts. In: Ingram DK, Baker GT, Shock NW (eds) The potential for nutritional modulation of aging processes. Food and Nutrition Press, Trumbell, pp 379–399
57.
Zurück zum Zitat Blokland A (1995) Acetylcholine: a neurotransmitter for learning and memory. Brain Res Brain Res Rev 21:285–300PubMedCrossRef Blokland A (1995) Acetylcholine: a neurotransmitter for learning and memory. Brain Res Brain Res Rev 21:285–300PubMedCrossRef
58.
Zurück zum Zitat Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128:199–202PubMedCrossRef Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128:199–202PubMedCrossRef
59.
Zurück zum Zitat Hoyer S, Hennenberg N, Knapp S, Lannert H, Martin E (1996) Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor. Ann NY Acad Sci 777:374–379PubMedCrossRef Hoyer S, Hennenberg N, Knapp S, Lannert H, Martin E (1996) Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor. Ann NY Acad Sci 777:374–379PubMedCrossRef
60.
Zurück zum Zitat Hoyer S (2000) Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease causes and consequences: an update. Exp Gerontol 35:1363–1372PubMedCrossRef Hoyer S (2000) Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease causes and consequences: an update. Exp Gerontol 35:1363–1372PubMedCrossRef
61.
Zurück zum Zitat Watt F (1996) Nuclear microscope analysis in Alzheimer’s and Parkinson’s disease: a review. Cell Mol Biol 42:17–26PubMed Watt F (1996) Nuclear microscope analysis in Alzheimer’s and Parkinson’s disease: a review. Cell Mol Biol 42:17–26PubMed
62.
Zurück zum Zitat Mattson MP, Chan SL (2001) Dysregulation of cellular calcium homeostasis in Alzheimer’s disease: bad genes and bad habits. J Mol Neurosci 17:205–224PubMedCrossRef Mattson MP, Chan SL (2001) Dysregulation of cellular calcium homeostasis in Alzheimer’s disease: bad genes and bad habits. J Mol Neurosci 17:205–224PubMedCrossRef
63.
Zurück zum Zitat Arlt S, Beisiegel U, Kontush A (2002) Lipid peroxidation in neurodegeneration: new insights into Alzheimer’s disease. Curr Opin Lipidol 13:289–294PubMedCrossRef Arlt S, Beisiegel U, Kontush A (2002) Lipid peroxidation in neurodegeneration: new insights into Alzheimer’s disease. Curr Opin Lipidol 13:289–294PubMedCrossRef
64.
Zurück zum Zitat Ansari MA, Ahmad AS, Ahmad M, Salim S, Yousuf S, Ishrat T, Islam F (2004) Selenium protects cerebral ischemia in rat brain mitochondria. Biol Trace Elem Res 101:73–86PubMedCrossRef Ansari MA, Ahmad AS, Ahmad M, Salim S, Yousuf S, Ishrat T, Islam F (2004) Selenium protects cerebral ischemia in rat brain mitochondria. Biol Trace Elem Res 101:73–86PubMedCrossRef
65.
Zurück zum Zitat Ahmad AS, Zia S, Sayeed I, Ansari MA, Ahmad M, Salim S, Yousuf S, Islam F (2005) Sodium selenite stimulates neurobehavior and neurochemical activities in rats. Biol Trace Elem Res 103:59–68PubMedCrossRef Ahmad AS, Zia S, Sayeed I, Ansari MA, Ahmad M, Salim S, Yousuf S, Islam F (2005) Sodium selenite stimulates neurobehavior and neurochemical activities in rats. Biol Trace Elem Res 103:59–68PubMedCrossRef
66.
Zurück zum Zitat Li P, Yamakuni T, Matsunaga K, Kondo S, Ohizumi Y (2003) Nardosinone enhances nerve growth factor-induced neurite outgrowth in a mitogen-activated protein kinase- and protein kinase C-dependent manner in PC12D cells. J Pharmacol Sci 93:122–125PubMedCrossRef Li P, Yamakuni T, Matsunaga K, Kondo S, Ohizumi Y (2003) Nardosinone enhances nerve growth factor-induced neurite outgrowth in a mitogen-activated protein kinase- and protein kinase C-dependent manner in PC12D cells. J Pharmacol Sci 93:122–125PubMedCrossRef
Metadaten
Titel
Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment
verfasst von
M. Badruzzaman Khan
Md. Nasrul Hoda
Tauheed Ishrat
Saif Ahmad
Mohd. Moshahid Khan
Ajmal Ahmad
Seema Yusuf
Fakhrul Islam
Publikationsdatum
01.10.2012
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 5/2012
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0880-1

Weitere Artikel der Ausgabe 5/2012

Neurological Sciences 5/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.